Viruses and Hodgkin lymphoma: No evidence of polyomavirus genomes in tumor biopsies

References

• Gutensohn N, Cole P. Epidemiology of Hodgkin's disease. Seminars in Oncology 1980; 7: 92–102
   PubMed Web of Science ®Google Scholar
• IARC. Proceedings of the IARC working group on the evaluation of carcinogenic risks to humans. Epstein-Barr virus and Kaposi's sarcoma herpesvirus/human herpesvirus 8. IARC, LyonFrance 1997, 17 – 24 June 1997
   Google Scholar
• Jarrett R F. Viruses and Hodgkin's lymphoma. Annals of Oncology 2002; 13: 23–29
   PubMed Web of Science ®Google Scholar
• Jarrett R F, Krajewski A S, Angus B, Freeland J, Taylor P R, Taylor G M, Alexander F E. The Scotland and Newcastle epidemiological study of Hodgkin's disease: impact of histopathological review and EBV status on incidence estimates. Journal of Clinical Pathology 2003; 56: 811–816
   PubMed Web of Science ®Google Scholar
• Gutensohn N M. Social class and age at diagnosis of Hodgkin's disease: new epidemiologic evidence for the ‘two-disease hypothesis’. Cancer Treatment Reports 1982; 66: 689–695
   PubMedGoogle Scholar
• Glaser S L. Regional variation in Hodgkin's disease incidence by histologic subtype in the US. Cancer 1987; 60: 2841–2847
   PubMed Web of Science ®Google Scholar
• Alexander F E, McKinney P A, Williams J, Ricketts T J, Cartwright R A. Epidemiological evidence for the ‘two-disease hypothesis’ in Hodgkin's disease. International Journal of Epidemiology 1991; 20: 354–361
   PubMed Web of Science ®Google Scholar
• Gutensohn N M, Shapiro D S. Social class risk factors among children with Hodgkin's disease. International Journal of Cancer 1982; 30: 433–435
   PubMed Web of Science ®Google Scholar
• Paffenbarger R S, Jr, Wing A L, Hyde R T. Characteristics in youth indicative of adult-onset Hodgkin's disease. Journal of the National Cancer Institute 1977; 58: 1489–1491
   PubMed Web of Science ®Google Scholar
• Alexander F E, Jarrett R F, Lawrence D, Armstrong A A, Freeland J, Gokhale D A, et al. Risk factors for Hodgkin's disease by Epstein-Barr virus (EBV) status: prior infection by EBV and other agents. British Journal of Cancer 2000; 82: 1117–1121
   PubMed Web of Science ®Google Scholar
• Chang E T, Zheng T, Weir E G, Borowitz M, Mann R B, Spiegelman D, Mueller N E. Childhood social environment and Hodgkin's lymphoma: new findings from a population-based case-control study. Cancer Epidemiology; Biomarkers Prevention 2004; 13: 1361–1370
   PubMed Web of Science ®Google Scholar
• Gallagher A, Perry J, Shield L, Freeland J, MacKenzie J, Jarrett R F. Viruses and Hodgkin disease: no evidence of novel herpesviruses in non-EBV-associated lesions. International Journal of Cancer 2002; 101: 259–264
   PubMed Web of Science ®Google Scholar
• Cole C N, Conzen S D. Polyomaviridae: the viruses and their replication. Fields virology4^th ed., D M Knipe, P M Howley. Lippincott Williams & Wilkins, Philadelphia 2001; 2141–2174
   Google Scholar
• Shah K, Nathanson N. Human exposure to SV40: review and comment. American Journal of Epidemiology 1976; 103: 1–12
   PubMed Web of Science ®Google Scholar
• Sangar D, Pipkin P A, Wood D J, Minor P D. Examination of poliovirus vaccine preparations for SV40 sequences. Biologicals 1999; 27: 1–10
   PubMed Web of Science ®Google Scholar
• Vilchez R A, Madden C R, Kozinetz C A, Halvorson S J, White Z S, Jorgensen J L, et al. Association between simian virus 40 and non-Hodgkin lymphoma. Lancet 2002; 359: 817–823
   PubMed Web of Science ®Google Scholar
• Shivapurkar N, Harada K, Reddy J, Scheuermann R H, Xu Y, McKenna R W, et al. Presence of simian virus 40 DNA sequences in human lymphomas. Lancet 2002; 359: 851–852
   PubMed Web of Science ®Google Scholar
• MacKenzie J, Wilson K S, Perry J, Gallagher A, Jarrett R F. Association between simian virus 40 DNA and lymphoma in the United Kingdom. Journal of the National Cancer Institute 2003; 95: 1001–1003
   PubMed Web of Science ®Google Scholar
• Brousset P, De A V, Gascoyne R D. Immunohistochemical investigation of SV40 large T antigen in Hodgkin and non-Hodgkin's lymphoma. International Journal of Cancer 2004; 112: 533–535
   PubMed Web of Science ®Google Scholar
• Martini F, Dolcetti R, Gloghini A, Iaccheri L, Carbone A, Boiocchi M, Tognon M. Simian-virus-40 footprints in human lymphoproliferative disorders of HIV- and HIV+ patients. International Journal of Cancer 1998; 78: 669–674
   PubMed Web of Science ®Google Scholar
• Nakatsuka S, Liu A, Dong Z, Nomura S, Takakuwa T, Miyazato H, Aozasa K. Simian virus 40 sequences in malignant lymphomas in Japan. Cancer Research 2003; 63: 7606–7608
   PubMed Web of Science ®Google Scholar
• McNees A L, White Z S, Zanwar P, Vilchez R A, Butel J S. Specific and quantitative detection of human polyomaviruses BKV, JCV, and SV40 by real time PCR. Journal of Clinical Virology 2005; 34: 52–62
   PubMed Web of Science ®Google Scholar
• Lopez-Rios F, Illei P B, Rusch V, Ladanyi M. Evidence against a role for SV40 infection in human mesotheliomas and high risk of false-positive PCR results owing to presence of SV40 sequences in common laboratory plasmids. Lancet 2004; 364: 1157–1166
   PubMed Web of Science ®Google Scholar
• Volter C, Hausen H, Alber D, de Villiers E M. Screening human tumor samples with a broad-spectrum polymerase chain reaction method for the detection of polyomaviruses. Virology 1997; 237: 389–396
   PubMed Web of Science ®Google Scholar
• Stein H. Hodgkin lymphomas: Introduction. World Health Organisation classification of tumours: Pathology and genetics of tumours of hematopoietic and lymphoid tissues, E S Jaffe, N L Harris, H Stein, J W Vardiman. IARC, Lyon 2001; 238–239
   Google Scholar
• Gallagher A, Armstrong A A, MacKenzie J, Shield L, Khan G, Lake A, et al. Detection of Epstein-Barr virus (EBV) genomes in the serum of patients with EBV-associated Hodgkin's disease. International Journal of Cancer 1999; 84: 442–448
   PubMed Web of Science ®Google Scholar
• Gluzman Y. SV40-transformed simian cells support the replication of early SV40 mutants. Cell 1981; 23: 175–182
   PubMed Web of Science ®Google Scholar
• Saiki R K, Gelfand D H, Stoffel S, Scharf S J, Higuchi R, Horn G T, et al. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 1988; 239: 487–491
   PubMed Web of Science ®Google Scholar
• Gan Y J, Razzouk B I, Su T, Sixbey J W. A defective, rearranged Epstein-Barr virus genome in EBER-negative and EBER-positive Hodgkin's disease. American Journal of Pathology 2002; 160: 781–786
   PubMed Web of Science ®Google Scholar
• Gallagher A, Perry J, Freeland J, Alexander F E, Carman W F, Shield L, et al. Hodgkin lymphoma and Epstein-Barr virus (EBV): No evidence to support hit-and-run mechanism in cases classified as non-EBV-associated. International Journal of Cancer 2003; 104: 624–630
   PubMed Web of Science ®Google Scholar
• Staratschek-Jox A, Kotkowski S, Belge G, Rudiger T, Bullerdiek J, Diehl V, Wolf J. Detection of Epstein-Barr virus in Hodgkin-Reed-Sternberg cells: no evidence for the persistence of integrated viral fragments inLatent membrane protein-1 (LMP-1)-negative classical Hodgkin's disease. American Journal of Pathology 2000; 156: 209–216
   PubMed Web of Science ®Google Scholar
• Knecht H, Odermatt B F. Rearranged Epstein-Barr virus genome in Hodgkin's disease and angioimmunoblastic lymphadenopathy: Swiss results. American Journal of Pathology 2003; 163: 369–370
   PubMed Web of Science ®Google Scholar